SCHEMBL6314802

SCHEMBL6314802

NCCCn1c(-c2ccc(-c3ccccc3)cc2)nc2cc(Cl)ccc2c1=O

nearest known ligand 0.83

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.83
MAPT P10636 5/20 0.56
TP53 P04637 1/20 0.54
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
RXFP1 Q9HBX9 2/20 0.53
POLB P06746 4/20 0.53
CASR P41180 1/20 0.50
LMNA P02545 1/20 0.49
RECQL P46063 1/20 0.49
RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314890 0.98 EGFR (0.86) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6307692 0.92 EGFR (0.69) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6307813 0.90 EGFR (0.73) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6315683 0.90 EGFR (0.69) EGFRMAPTTP53ALDH1A1RXFP1
SCHEMBL6306955 0.90 EGFR (0.72) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6313171 0.89 EGFR (0.69) EGFRMAPTTP53SMN1; SMN2RXFP1
SCHEMBL6308088 0.88 EGFR (0.70) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6314002 0.87 CASR (0.65) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6313852 0.86 EGFR (0.64) EGFRMAPTTP53ALDH1A1SMN1; SMN2
SCHEMBL6306215 0.86 EGFR (0.64) EGFRMAPTTP53SMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6890930-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed
EP-1216235-A1 QUINAZOLINONES MERCK PATENT GmbH (DE) 2002-06-26 EP disclosed
WO-2001023365-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed